Comments
Loading...

Inhibrx Biosciences (INBX) Stock Price, Quote, News & History

INBXNASDAQ
Logo brought to you by Benzinga Data
$73.32
At close: Nov 12, 4:00 PM EST
$72.10
-1.22-1.66%
Pre-Market: 4:41 AM EST
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Analyst Trends and Forecast

1
May
1
Aug
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.8
Strong Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Key Statistics

Open
-
Close
-
Volume / Avg.
0 / 321.11K
Day Range
- - -
52 Wk Range
10.81 - 86.64
Market Cap
$1.04B
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
58
Short Interest
9.76%
Days to Cover
1

About

Sector
Health Care
Industry
Biotechnology
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates inc...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
INBX
UPB

FAQ

Q

How do I buy Inhibrx Biosciences (INBX) stock?

A

You can purchase shares of Inhibrx Biosciences (NASDAQ:INBX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Inhibrx Biosciences (INBX) competitors?

Q

What is the forecast, or price target, for Inhibrx Biosciences (INBX) stock?

A

Inhibrx Biosciences has a consensus price target of $40.50.

Q

What is the current price for Inhibrx Biosciences (INBX)?

A

The stock price for Inhibrx Biosciences (NASDAQ: INBX) is $72.1 last updated November 12, 2025 at 7:21 PM EST.

Q

Does Inhibrx Biosciences (INBX) pay a dividend?

A

There are no upcoming dividends for Inhibrx Biosciences.

Q

When is Inhibrx Biosciences (NASDAQ:INBX) reporting earnings?

A

Inhibrx Biosciences’s Q3 earnings are confirmed for Tuesday, November 25, 2025.

Q

Is Inhibrx Biosciences (INBX) going to split?

A

There is no upcoming split for Inhibrx Biosciences.

Q

What sector and industry does Inhibrx Biosciences (INBX) operate in?

A

Inhibrx Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch